• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the editor for the article "Evaluation of histological variants of upper tract urothelial carcinoma as prognostic factor after radical nephroureterectomy".

作者信息

Urabe Fumihiko, Uchida Naoki, Tsuzuki Shunsuke, Kimura Takahiro

机构信息

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

出版信息

World J Urol. 2024 May 2;42(1):284. doi: 10.1007/s00345-024-05009-x.

DOI:10.1007/s00345-024-05009-x
PMID:38696000
Abstract
摘要

相似文献

1
Letter to the editor for the article "Evaluation of histological variants of upper tract urothelial carcinoma as prognostic factor after radical nephroureterectomy".致编辑的信：关于文章《根治性肾输尿管切除术后上尿路尿路上皮癌组织学变异作为预后因素的评估》
World J Urol. 2024 May 2;42(1):284. doi: 10.1007/s00345-024-05009-x.
2
Letter to the editor for the article "Evaluation of histological variants of upper tract urothelial carcinoma as prognostic factor after radical nephroureterectomy".致编辑的信：关于文章《根治性肾输尿管切除术后上尿路尿路上皮癌组织学变异作为预后因素的评估》
World J Urol. 2024 May 2;42(1):286. doi: 10.1007/s00345-024-05005-1.
3
Letter to the editor for the article "Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma".致编辑的信：关于“上尿路尿路上皮癌患者根治性肾输尿管切除术后病理分期上调的预测”一文
World J Urol. 2024 Apr 28;42(1):268. doi: 10.1007/s00345-024-05007-z.
4
Letter to the Editor Re: Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence upper tract urothelial carcinoma after radical nephroureterectomy.致编辑的信：关于：组织学变异与根治性肾输尿管切除术后上尿路尿路上皮癌更多的非尿路上皮途径复发相关，但膀胱内复发较少。
Int J Urol. 2024 Apr;31(4):420. doi: 10.1111/iju.15404. Epub 2024 Jan 29.
5
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.组织学亚型对上尿路尿路上皮癌患者临床结局的影响。
J Urol. 2012 Aug;188(2):398-404. doi: 10.1016/j.juro.2012.04.009. Epub 2012 Jun 13.
6
Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence upper tract urothelial carcinoma after radical nephroureterectomy.组织学变异与根治性肾输尿管切除术后上尿路尿路上皮癌更多的非尿路上皮途径复发相关，但膀胱内复发较少。
Int J Urol. 2024 Apr;31(4):421. doi: 10.1111/iju.15455. Epub 2024 Apr 3.
7
Outcomes for patients with pT0 disease after radical nephroureterectomy for upper-tract urothelial carcinoma.上尿路尿路上皮癌根治性肾输尿管切除术后pT0期疾病患者的预后。
BJU Int. 2009 Jan;103(1):3-4. doi: 10.1111/j.1464-410X.2008.07938.x. Epub 2008 Aug 18.
8
Letter to the editor for the article "Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies".致编辑的信：关于文章《内镜干预与根治性肾输尿管切除术治疗局限性上尿路尿路上皮癌：比较研究的系统评价和荟萃分析》
World J Urol. 2024 Aug 7;42(1):472. doi: 10.1007/s00345-024-05180-1.
9
Editorial Comment on Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.关于变异组织学与根治性肾输尿管切除术后上尿路尿路上皮癌更多的非尿路复发但更少的膀胱内复发相关的社论评论。
Int J Urol. 2024 Apr;31(4):418-419. doi: 10.1111/iju.15417. Epub 2024 Feb 1.
10
Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.肾输尿管切除术治疗上尿路上皮癌中变异组织学的预后价值：系统评价和荟萃分析。
J Urol. 2020 Jun;203(6):1075-1084. doi: 10.1097/JU.0000000000000523. Epub 2019 Sep 3.

本文引用的文献

1
Evaluation of histological variants of upper tract urothelial carcinoma as prognostic factor after radical nephroureterectomy.根治性肾输尿管切除术治疗后，上尿路尿路上皮癌组织学亚型作为预后因素的评估。
World J Urol. 2024 Apr 9;42(1):225. doi: 10.1007/s00345-024-04878-6.
2
Effect of a variant histology on the oncological outcomes of Japanese patients with upper tract urothelial carcinomas after radical nephroureterectomy: a multicenter retrospective study.变异组织学对日本上尿路尿路上皮癌患者根治性肾输尿管切除术后肿瘤学结局的影响：一项多中心回顾性研究。
Transl Androl Urol. 2024 Mar 31;13(3):414-422. doi: 10.21037/tau-23-561. Epub 2024 Mar 6.
3
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study.
辅助免疫治疗候选药物在上尿路尿路上皮癌中的真实世界结局：一项多中心队列研究的结果。
Int J Clin Oncol. 2024 Jan;29(1):55-63. doi: 10.1007/s10147-023-02424-9. Epub 2023 Oct 21.
4
Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis.影响上尿路尿路上皮癌患者生存的病理因素：系统评价和荟萃分析。
Int Braz J Urol. 2022 May-Jun;48(3):406-455. doi: 10.1590/S1677-5538.IBJU.2020.1032.
5
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.在上尿路尿路上皮癌中的辅助化疗（POUT 试验）：一项 3 期、开放标签、随机对照试验。
Lancet. 2020 Apr 18;395(10232):1268-1277. doi: 10.1016/S0140-6736(20)30415-3. Epub 2020 Mar 5.
6
Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?辅助化疗对根治性膀胱切除术治疗肌层浸润性膀胱癌伴不良特征和变异组织学患者的影响：组织学亚型重要吗？
Cancer. 2019 May 1;125(9):1449-1458. doi: 10.1002/cncr.31952. Epub 2019 Jan 8.
7
Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes.膀胱微乳头状尿路上皮癌：疾病特征和治疗结局的系统评价和荟萃分析。
Eur Urol. 2019 Apr;75(4):649-658. doi: 10.1016/j.eururo.2018.11.052. Epub 2018 Dec 13.
8
Squamous Differentiation Predicts Poor Response to Cisplatin-Based Chemotherapy and Unfavorable Prognosis in Urothelial Carcinoma of the Urinary Bladder.鳞状分化预示着膀胱尿路上皮癌对顺铂化疗反应不佳及预后不良。
Clin Genitourin Cancer. 2017 Dec;15(6):e1063-e1067. doi: 10.1016/j.clgc.2017.07.008. Epub 2017 Jul 22.
9
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).混合组织学特征是否会影响局部晚期膀胱癌患者接受新辅助含铂联合化疗的生存获益？西南肿瘤协作组定向联合组研究（S8710）的二次分析。
BJU Int. 2011 Sep;108(5):693-9. doi: 10.1111/j.1464-410X.2010.09900.x. Epub 2010 Nov 24.